pubmed-article:9659085 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9659085 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:9659085 | lifeskim:mentions | umls-concept:C0027831 | lld:lifeskim |
pubmed-article:9659085 | lifeskim:mentions | umls-concept:C0016441 | lld:lifeskim |
pubmed-article:9659085 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
pubmed-article:9659085 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
pubmed-article:9659085 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:9659085 | pubmed:dateCreated | 1998-7-21 | lld:pubmed |
pubmed-article:9659085 | pubmed:abstractText | To establish the prevalence and incidence of symptoms and complications in children with neurofibromatosis type 1 (NF1) and to assess possible risk factors for the development of complications. | lld:pubmed |
pubmed-article:9659085 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9659085 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9659085 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9659085 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9659085 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9659085 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9659085 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9659085 | pubmed:language | eng | lld:pubmed |
pubmed-article:9659085 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9659085 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:9659085 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9659085 | pubmed:month | May | lld:pubmed |
pubmed-article:9659085 | pubmed:issn | 1468-2044 | lld:pubmed |
pubmed-article:9659085 | pubmed:author | pubmed-author:NiermeijerM... | lld:pubmed |
pubmed-article:9659085 | pubmed:author | pubmed-author:HalleyD JDJ | lld:pubmed |
pubmed-article:9659085 | pubmed:author | pubmed-author:OranjeA PAP | lld:pubmed |
pubmed-article:9659085 | pubmed:author | pubmed-author:van den... | lld:pubmed |
pubmed-article:9659085 | pubmed:author | pubmed-author:SimonszH JHJ | lld:pubmed |
pubmed-article:9659085 | pubmed:author | pubmed-author:StroinkHH | lld:pubmed |
pubmed-article:9659085 | pubmed:author | pubmed-author:de... | lld:pubmed |
pubmed-article:9659085 | pubmed:author | pubmed-author:CnossenM HMH | lld:pubmed |
pubmed-article:9659085 | pubmed:author | pubmed-author:van den... | lld:pubmed |
pubmed-article:9659085 | pubmed:author | pubmed-author:WaasdorpC MCM | lld:pubmed |
pubmed-article:9659085 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:9659085 | pubmed:volume | 78 | lld:pubmed |
pubmed-article:9659085 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9659085 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9659085 | pubmed:pagination | 408-12 | lld:pubmed |
pubmed-article:9659085 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:meshHeading | pubmed-meshheading:9659085-... | lld:pubmed |
pubmed-article:9659085 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9659085 | pubmed:articleTitle | A prospective 10 year follow up study of patients with neurofibromatosis type 1. | lld:pubmed |
pubmed-article:9659085 | pubmed:affiliation | Department of Paediatrics, University Hospital Sophia/Dijkzigt, Rotterdam, Netherlands. cnossen@alkg.azr.nl | lld:pubmed |
pubmed-article:9659085 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9659085 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9659085 | lld:pubmed |